Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $748.5000 (-0.89%) ($748.5000 - $748.5000) on Wed. May. 10, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.58% (three month average) | RSI | 33 | Latest Price | $748.5000(-0.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.4% a day on average for past five trading days. | Weekly Trend | REGN declines -2.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(46%) DIA(33%) VYM(32%) IWD(30%) | Factors Impacting REGN price | REGN will decline at least -0.79% in a week (0% probabilities). VXX(-28%) VIXM(-21%) TBT(-5%) UUP(-4%) ARKK(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.79% (StdDev 1.58%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $790.24 | 5 Day Moving Average | $754.27(-0.76%) | 10 Day Moving Average | $776.08(-3.55%) | 20 Day Moving Average | $790.24(-5.28%) | To recent high | -9.9% | To recent low | 1.7% | Market Cap | $79.362b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |